nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Gemcitabine—lung cancer	0.335	1	CrCtD
Lamivudine—ABCC3—lung cancer	0.0915	0.593	CbGaD
Lamivudine—Zalcitabine—Gemcitabine—lung cancer	0.0903	0.522	CrCrCtD
Lamivudine—CMPK1—Gemcitabine—lung cancer	0.0548	0.239	CbGbCtD
Lamivudine—ABCG2—lung cancer	0.0445	0.288	CbGaD
Lamivudine—Cytarabine—Gemcitabine—lung cancer	0.0434	0.251	CrCrCtD
Lamivudine—Decitabine—Gemcitabine—lung cancer	0.0393	0.227	CrCrCtD
Lamivudine—DCK—Pemetrexed—lung cancer	0.0389	0.17	CbGbCtD
Lamivudine—ABCB1—lung cancer	0.0185	0.12	CbGaD
Lamivudine—DCK—Gemcitabine—lung cancer	0.014	0.0612	CbGbCtD
Lamivudine—SLC22A3—Irinotecan—lung cancer	0.00609	0.0266	CbGbCtD
Lamivudine—ABCG2—Topotecan—lung cancer	0.00545	0.0238	CbGbCtD
Lamivudine—ABCC3—Cisplatin—lung cancer	0.00528	0.0231	CbGbCtD
Lamivudine—ABCC3—Etoposide—lung cancer	0.00519	0.0227	CbGbCtD
Lamivudine—ABCG2—Gefitinib—lung cancer	0.00498	0.0218	CbGbCtD
Lamivudine—ABCG2—Teniposide—lung cancer	0.00483	0.0211	CbGbCtD
Lamivudine—ABCC1—Paclitaxel—lung cancer	0.00403	0.0176	CbGbCtD
Lamivudine—ABCC1—Irinotecan—lung cancer	0.00398	0.0174	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—lung cancer	0.00354	0.0155	CbGbCtD
Lamivudine—ABCC1—Vinblastine—lung cancer	0.00353	0.0154	CbGbCtD
Lamivudine—ABCC3—Methotrexate—lung cancer	0.00343	0.015	CbGbCtD
Lamivudine—SLC22A2—Vinblastine—lung cancer	0.0032	0.014	CbGbCtD
Lamivudine—ABCC1—Etoposide—lung cancer	0.00318	0.0139	CbGbCtD
Lamivudine—ABCC2—Paclitaxel—lung cancer	0.00298	0.013	CbGbCtD
Lamivudine—ABCG2—Erlotinib—lung cancer	0.00295	0.0129	CbGbCtD
Lamivudine—ABCC2—Irinotecan—lung cancer	0.00294	0.0129	CbGbCtD
Lamivudine—SLC22A2—Cisplatin—lung cancer	0.00294	0.0128	CbGbCtD
Lamivudine—ABCC1—Docetaxel—lung cancer	0.00291	0.0127	CbGbCtD
Lamivudine—ABCG2—Paclitaxel—lung cancer	0.0027	0.0118	CbGbCtD
Lamivudine—ABCG2—Irinotecan—lung cancer	0.00266	0.0116	CbGbCtD
Lamivudine—ABCC4—Methotrexate—lung cancer	0.00262	0.0114	CbGbCtD
Lamivudine—ABCC2—Vinblastine—lung cancer	0.00262	0.0114	CbGbCtD
Lamivudine—ABCC2—Cisplatin—lung cancer	0.0024	0.0105	CbGbCtD
Lamivudine—ABCC2—Etoposide—lung cancer	0.00236	0.0103	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—lung cancer	0.00217	0.00949	CbGbCtD
Lamivudine—ABCG2—Cisplatin—lung cancer	0.00217	0.00948	CbGbCtD
Lamivudine—ABCC2—Docetaxel—lung cancer	0.00216	0.00942	CbGbCtD
Lamivudine—ABCG2—Etoposide—lung cancer	0.00213	0.00931	CbGbCtD
Lamivudine—ABCC1—Methotrexate—lung cancer	0.0021	0.00919	CbGbCtD
Lamivudine—ABCB1—Topotecan—lung cancer	0.00196	0.00858	CbGbCtD
Lamivudine—ABCG2—Docetaxel—lung cancer	0.00195	0.00852	CbGbCtD
Lamivudine—ABCB1—Gefitinib—lung cancer	0.0018	0.00785	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—lung cancer	0.00161	0.00703	CbGbCtD
Lamivudine—ABCC2—Methotrexate—lung cancer	0.00156	0.00681	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—lung cancer	0.00145	0.00635	CbGbCtD
Lamivudine—ABCG2—Methotrexate—lung cancer	0.00141	0.00615	CbGbCtD
Lamivudine—ABCB1—Vinorelbine—lung cancer	0.00138	0.00605	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—lung cancer	0.00114	0.00498	CbGbCtD
Lamivudine—ABCB1—Crizotinib—lung cancer	0.0011	0.00481	CbGbCtD
Lamivudine—ABCB1—Gemcitabine—lung cancer	0.00108	0.0047	CbGbCtD
Lamivudine—ABCB1—Erlotinib—lung cancer	0.00106	0.00464	CbGbCtD
Lamivudine—ABCB1—Paclitaxel—lung cancer	0.000972	0.00425	CbGbCtD
Lamivudine—ABCB1—Irinotecan—lung cancer	0.000959	0.00419	CbGbCtD
Lamivudine—NT5C—respiratory system—lung cancer	0.000948	0.0738	CbGeAlD
Lamivudine—PCYT1A—respiratory system—lung cancer	0.000889	0.0693	CbGeAlD
Lamivudine—ABCB1—Vinblastine—lung cancer	0.000853	0.00373	CbGbCtD
Lamivudine—ABCB1—Cisplatin—lung cancer	0.000782	0.00342	CbGbCtD
Lamivudine—ABCB1—Etoposide—lung cancer	0.000768	0.00336	CbGbCtD
Lamivudine—ABCB1—Docetaxel—lung cancer	0.000703	0.00307	CbGbCtD
Lamivudine—Gemcitabine—RRM1—lung cancer	0.000621	0.656	CrCbGaD
Lamivudine—NME1—respiratory system—lung cancer	0.000595	0.0463	CbGeAlD
Lamivudine—CMPK1—respiratory system—lung cancer	0.000573	0.0447	CbGeAlD
Lamivudine—NME2—respiratory system—lung cancer	0.00056	0.0436	CbGeAlD
Lamivudine—ABCB1—Doxorubicin—lung cancer	0.000524	0.00229	CbGbCtD
Lamivudine—ABCB1—Methotrexate—lung cancer	0.000508	0.00222	CbGbCtD
Lamivudine—NT5C—lung—lung cancer	0.000503	0.0392	CbGeAlD
Lamivudine—NME1—Bosutinib—Gefitinib—lung cancer	0.000485	0.454	CbGdCrCtD
Lamivudine—PCYT1A—lung—lung cancer	0.000472	0.0368	CbGeAlD
Lamivudine—CMPK1—bronchus—lung cancer	0.000472	0.0367	CbGeAlD
Lamivudine—NME2—epithelium—lung cancer	0.000468	0.0365	CbGeAlD
Lamivudine—NME2—bronchus—lung cancer	0.000461	0.0359	CbGeAlD
Lamivudine—CMPK1—cardiac atrium—lung cancer	0.000398	0.031	CbGeAlD
Lamivudine—NME1-NME2—lymph node—lung cancer	0.000371	0.0289	CbGeAlD
Lamivudine—NME1—bone marrow—lung cancer	0.000349	0.0272	CbGeAlD
Lamivudine—NT5C—lymph node—lung cancer	0.000344	0.0268	CbGeAlD
Lamivudine—CMPK1—bone marrow—lung cancer	0.000336	0.0262	CbGeAlD
Lamivudine—NME1—lung—lung cancer	0.000316	0.0246	CbGeAlD
Lamivudine—CMPK1—lung—lung cancer	0.000304	0.0237	CbGeAlD
Lamivudine—NME2—lung—lung cancer	0.000297	0.0232	CbGeAlD
Lamivudine—ABCC3—respiratory system—lung cancer	0.000273	0.0213	CbGeAlD
Lamivudine—Gemcitabine—TYMS—lung cancer	0.00026	0.275	CrCbGaD
Lamivudine—DCK—bronchus—lung cancer	0.000235	0.0183	CbGeAlD
Lamivudine—NME1—lymph node—lung cancer	0.000216	0.0168	CbGeAlD
Lamivudine—DCK—trachea—lung cancer	0.000211	0.0164	CbGeAlD
Lamivudine—CMPK1—lymph node—lung cancer	0.000208	0.0162	CbGeAlD
Lamivudine—NME2—lymph node—lung cancer	0.000203	0.0158	CbGeAlD
Lamivudine—DCK—cardiac atrium—lung cancer	0.000198	0.0154	CbGeAlD
Lamivudine—ABCC4—bronchus—lung cancer	0.000186	0.0145	CbGeAlD
Lamivudine—NME1—Afatinib—Gefitinib—lung cancer	0.000183	0.171	CbGdCrCtD
Lamivudine—DCK—Topotecan—Irinotecan—lung cancer	0.000182	0.17	CbGdCrCtD
Lamivudine—NME1—Gefitinib—Erlotinib—lung cancer	0.00018	0.168	CbGdCrCtD
Lamivudine—DCK—bone marrow—lung cancer	0.000167	0.013	CbGeAlD
Lamivudine—ABCC1—bronchus—lung cancer	0.000158	0.0123	CbGeAlD
Lamivudine—DCK—lung—lung cancer	0.000152	0.0118	CbGeAlD
Lamivudine—ABCC3—lung—lung cancer	0.000145	0.0113	CbGeAlD
Lamivudine—ABCC1—trachea—lung cancer	0.000142	0.0111	CbGeAlD
Lamivudine—ABCC1—cardiac atrium—lung cancer	0.000134	0.0104	CbGeAlD
Lamivudine—ABCC4—bone marrow—lung cancer	0.000132	0.0103	CbGeAlD
Lamivudine—SLC22A3—lung—lung cancer	0.000124	0.00962	CbGeAlD
Lamivudine—ABCC4—lung—lung cancer	0.00012	0.00933	CbGeAlD
Lamivudine—DCK—lymph node—lung cancer	0.000104	0.00807	CbGeAlD
Lamivudine—ABCC1—lung—lung cancer	0.000102	0.00796	CbGeAlD
Lamivudine—ABCC3—lymph node—lung cancer	9.92e-05	0.00773	CbGeAlD
Lamivudine—ABCG2—bone marrow—lung cancer	9.33e-05	0.00727	CbGeAlD
Lamivudine—ABCG2—lung—lung cancer	8.45e-05	0.00659	CbGeAlD
Lamivudine—SLC22A3—lymph node—lung cancer	8.45e-05	0.00658	CbGeAlD
Lamivudine—ABCC4—lymph node—lung cancer	8.19e-05	0.00638	CbGeAlD
Lamivudine—ABCC2—lymph node—lung cancer	7.93e-05	0.00618	CbGeAlD
Lamivudine—ABCB1—respiratory system—lung cancer	7.85e-05	0.00612	CbGeAlD
Lamivudine—ABCC1—lymph node—lung cancer	6.98e-05	0.00544	CbGeAlD
Lamivudine—Gemcitabine—ABCB1—lung cancer	6.6e-05	0.0696	CrCbGaD
Lamivudine—ABCB1—epithelium—lung cancer	6.56e-05	0.00511	CbGeAlD
Lamivudine—ABCB1—trachea—lung cancer	5.8e-05	0.00452	CbGeAlD
Lamivudine—ABCG2—lymph node—lung cancer	5.78e-05	0.0045	CbGeAlD
Lamivudine—ABCB1—bone marrow—lung cancer	4.6e-05	0.00358	CbGeAlD
Lamivudine—ABCB1—lung—lung cancer	4.17e-05	0.00325	CbGeAlD
Lamivudine—DCK—Epirubicin—Doxorubicin—lung cancer	3.95e-05	0.0369	CbGdCrCtD
Lamivudine—ABCB1—lymph node—lung cancer	2.85e-05	0.00222	CbGeAlD
Lamivudine—Somnolence—Paclitaxel—lung cancer	1.92e-05	0.000378	CcSEcCtD
Lamivudine—Decreased appetite—Etoposide—lung cancer	1.91e-05	0.000377	CcSEcCtD
Lamivudine—Chest pain—Docetaxel—lung cancer	1.91e-05	0.000376	CcSEcCtD
Lamivudine—Myalgia—Docetaxel—lung cancer	1.91e-05	0.000376	CcSEcCtD
Lamivudine—Arthralgia—Docetaxel—lung cancer	1.91e-05	0.000376	CcSEcCtD
Lamivudine—Pancytopenia—Doxorubicin—lung cancer	1.9e-05	0.000376	CcSEcCtD
Lamivudine—Nausea—Vinorelbine—lung cancer	1.9e-05	0.000375	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Etoposide—lung cancer	1.9e-05	0.000374	CcSEcCtD
Lamivudine—Dyspepsia—Paclitaxel—lung cancer	1.9e-05	0.000374	CcSEcCtD
Lamivudine—Body temperature increased—Cisplatin—lung cancer	1.9e-05	0.000374	CcSEcCtD
Lamivudine—Asthenia—Irinotecan—lung cancer	1.9e-05	0.000374	CcSEcCtD
Lamivudine—Fatigue—Etoposide—lung cancer	1.9e-05	0.000374	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	1.89e-05	0.000373	CcSEcCtD
Lamivudine—Pain—Etoposide—lung cancer	1.88e-05	0.000371	CcSEcCtD
Lamivudine—Constipation—Etoposide—lung cancer	1.88e-05	0.000371	CcSEcCtD
Lamivudine—Dysuria—Doxorubicin—lung cancer	1.88e-05	0.00037	CcSEcCtD
Lamivudine—Neutropenia—Doxorubicin—lung cancer	1.88e-05	0.00037	CcSEcCtD
Lamivudine—Decreased appetite—Paclitaxel—lung cancer	1.87e-05	0.00037	CcSEcCtD
Lamivudine—Dry mouth—Docetaxel—lung cancer	1.86e-05	0.000368	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Paclitaxel—lung cancer	1.86e-05	0.000367	CcSEcCtD
Lamivudine—Fatigue—Paclitaxel—lung cancer	1.86e-05	0.000367	CcSEcCtD
Lamivudine—Hepatitis—Methotrexate—lung cancer	1.85e-05	0.000366	CcSEcCtD
Lamivudine—Pollakiuria—Doxorubicin—lung cancer	1.85e-05	0.000365	CcSEcCtD
Lamivudine—Asthenia—Gemcitabine—lung cancer	1.85e-05	0.000364	CcSEcCtD
Lamivudine—Constipation—Paclitaxel—lung cancer	1.84e-05	0.000364	CcSEcCtD
Lamivudine—Pain—Paclitaxel—lung cancer	1.84e-05	0.000364	CcSEcCtD
Lamivudine—Confusional state—Docetaxel—lung cancer	1.84e-05	0.000363	CcSEcCtD
Lamivudine—Pharyngitis—Methotrexate—lung cancer	1.84e-05	0.000363	CcSEcCtD
Lamivudine—Anaphylactic shock—Docetaxel—lung cancer	1.83e-05	0.00036	CcSEcCtD
Lamivudine—Oedema—Docetaxel—lung cancer	1.83e-05	0.00036	CcSEcCtD
Lamivudine—Pruritus—Gemcitabine—lung cancer	1.82e-05	0.000359	CcSEcCtD
Lamivudine—Infection—Docetaxel—lung cancer	1.82e-05	0.000358	CcSEcCtD
Lamivudine—Feeling abnormal—Etoposide—lung cancer	1.81e-05	0.000357	CcSEcCtD
Lamivudine—Hyperglycaemia—Doxorubicin—lung cancer	1.81e-05	0.000357	CcSEcCtD
Lamivudine—Diarrhoea—Irinotecan—lung cancer	1.81e-05	0.000357	CcSEcCtD
Lamivudine—Gastrointestinal pain—Etoposide—lung cancer	1.8e-05	0.000355	CcSEcCtD
Lamivudine—Shock—Docetaxel—lung cancer	1.8e-05	0.000355	CcSEcCtD
Lamivudine—Nervous system disorder—Docetaxel—lung cancer	1.79e-05	0.000353	CcSEcCtD
Lamivudine—Thrombocytopenia—Docetaxel—lung cancer	1.79e-05	0.000353	CcSEcCtD
Lamivudine—Feeling abnormal—Paclitaxel—lung cancer	1.78e-05	0.00035	CcSEcCtD
Lamivudine—Skin disorder—Docetaxel—lung cancer	1.78e-05	0.00035	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	1.77e-05	0.00035	CcSEcCtD
Lamivudine—Hypersensitivity—Cisplatin—lung cancer	1.77e-05	0.000349	CcSEcCtD
Lamivudine—Gastrointestinal pain—Paclitaxel—lung cancer	1.76e-05	0.000348	CcSEcCtD
Lamivudine—Diarrhoea—Gemcitabine—lung cancer	1.76e-05	0.000347	CcSEcCtD
Lamivudine—Renal failure—Doxorubicin—lung cancer	1.76e-05	0.000347	CcSEcCtD
Lamivudine—Erythema multiforme—Methotrexate—lung cancer	1.75e-05	0.000346	CcSEcCtD
Lamivudine—Neuropathy peripheral—Doxorubicin—lung cancer	1.75e-05	0.000346	CcSEcCtD
Lamivudine—Dizziness—Irinotecan—lung cancer	1.75e-05	0.000345	CcSEcCtD
Lamivudine—Urticaria—Etoposide—lung cancer	1.75e-05	0.000344	CcSEcCtD
Lamivudine—Jaundice—Doxorubicin—lung cancer	1.74e-05	0.000344	CcSEcCtD
Lamivudine—Stomatitis—Doxorubicin—lung cancer	1.74e-05	0.000344	CcSEcCtD
Lamivudine—Anorexia—Docetaxel—lung cancer	1.74e-05	0.000344	CcSEcCtD
Lamivudine—Abdominal pain—Etoposide—lung cancer	1.74e-05	0.000343	CcSEcCtD
Lamivudine—Body temperature increased—Etoposide—lung cancer	1.74e-05	0.000343	CcSEcCtD
Lamivudine—Asthenia—Cisplatin—lung cancer	1.72e-05	0.00034	CcSEcCtD
Lamivudine—Sweating—Doxorubicin—lung cancer	1.71e-05	0.000338	CcSEcCtD
Lamivudine—Urticaria—Paclitaxel—lung cancer	1.71e-05	0.000338	CcSEcCtD
Lamivudine—Hypotension—Docetaxel—lung cancer	1.71e-05	0.000337	CcSEcCtD
Lamivudine—Abdominal pain—Paclitaxel—lung cancer	1.7e-05	0.000336	CcSEcCtD
Lamivudine—Body temperature increased—Paclitaxel—lung cancer	1.7e-05	0.000336	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—lung cancer	1.69e-05	0.000334	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—lung cancer	1.69e-05	0.000333	CcSEcCtD
Lamivudine—Vomiting—Irinotecan—lung cancer	1.68e-05	0.000331	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—lung cancer	1.68e-05	0.000331	CcSEcCtD
Lamivudine—Immune system disorder—Methotrexate—lung cancer	1.67e-05	0.00033	CcSEcCtD
Lamivudine—Mediastinal disorder—Methotrexate—lung cancer	1.67e-05	0.000329	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—lung cancer	1.67e-05	0.000329	CcSEcCtD
Lamivudine—Rash—Irinotecan—lung cancer	1.67e-05	0.000329	CcSEcCtD
Lamivudine—Dermatitis—Irinotecan—lung cancer	1.67e-05	0.000328	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Docetaxel—lung cancer	1.67e-05	0.000328	CcSEcCtD
Lamivudine—Chills—Methotrexate—lung cancer	1.66e-05	0.000328	CcSEcCtD
Lamivudine—Headache—Irinotecan—lung cancer	1.66e-05	0.000327	CcSEcCtD
Lamivudine—Insomnia—Docetaxel—lung cancer	1.65e-05	0.000326	CcSEcCtD
Lamivudine—Diarrhoea—Cisplatin—lung cancer	1.64e-05	0.000324	CcSEcCtD
Lamivudine—Paraesthesia—Docetaxel—lung cancer	1.64e-05	0.000324	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—lung cancer	1.64e-05	0.000323	CcSEcCtD
Lamivudine—Vomiting—Gemcitabine—lung cancer	1.64e-05	0.000323	CcSEcCtD
Lamivudine—Dyspnoea—Docetaxel—lung cancer	1.63e-05	0.000321	CcSEcCtD
Lamivudine—Somnolence—Docetaxel—lung cancer	1.62e-05	0.00032	CcSEcCtD
Lamivudine—Rash—Gemcitabine—lung cancer	1.62e-05	0.00032	CcSEcCtD
Lamivudine—Dermatitis—Gemcitabine—lung cancer	1.62e-05	0.00032	CcSEcCtD
Lamivudine—Hypersensitivity—Etoposide—lung cancer	1.62e-05	0.000319	CcSEcCtD
Lamivudine—Erythema—Methotrexate—lung cancer	1.61e-05	0.000318	CcSEcCtD
Lamivudine—Malnutrition—Methotrexate—lung cancer	1.61e-05	0.000318	CcSEcCtD
Lamivudine—Headache—Gemcitabine—lung cancer	1.61e-05	0.000318	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—lung cancer	1.61e-05	0.000317	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—lung cancer	1.61e-05	0.000317	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—lung cancer	1.61e-05	0.000317	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—lung cancer	1.6e-05	0.000315	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—lung cancer	1.59e-05	0.000314	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—lung cancer	1.59e-05	0.000313	CcSEcCtD
Lamivudine—Hypersensitivity—Paclitaxel—lung cancer	1.59e-05	0.000313	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—lung cancer	1.58e-05	0.000312	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—lung cancer	1.58e-05	0.000311	CcSEcCtD
Lamivudine—Asthenia—Etoposide—lung cancer	1.58e-05	0.000311	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—lung cancer	1.58e-05	0.000311	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—lung cancer	1.58e-05	0.000311	CcSEcCtD
Lamivudine—Nausea—Irinotecan—lung cancer	1.57e-05	0.00031	CcSEcCtD
Lamivudine—Constipation—Docetaxel—lung cancer	1.56e-05	0.000308	CcSEcCtD
Lamivudine—Pain—Docetaxel—lung cancer	1.56e-05	0.000308	CcSEcCtD
Lamivudine—Back pain—Methotrexate—lung cancer	1.56e-05	0.000308	CcSEcCtD
Lamivudine—Pruritus—Etoposide—lung cancer	1.56e-05	0.000307	CcSEcCtD
Lamivudine—Asthenia—Paclitaxel—lung cancer	1.55e-05	0.000305	CcSEcCtD
Lamivudine—Nausea—Gemcitabine—lung cancer	1.53e-05	0.000302	CcSEcCtD
Lamivudine—Vomiting—Cisplatin—lung cancer	1.53e-05	0.000301	CcSEcCtD
Lamivudine—Pruritus—Paclitaxel—lung cancer	1.53e-05	0.000301	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—lung cancer	1.52e-05	0.000299	CcSEcCtD
Lamivudine—Rash—Cisplatin—lung cancer	1.51e-05	0.000298	CcSEcCtD
Lamivudine—Dermatitis—Cisplatin—lung cancer	1.51e-05	0.000298	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—lung cancer	1.51e-05	0.000297	CcSEcCtD
Lamivudine—Diarrhoea—Etoposide—lung cancer	1.5e-05	0.000297	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—lung cancer	1.5e-05	0.000295	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—lung cancer	1.49e-05	0.000295	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—lung cancer	1.49e-05	0.000294	CcSEcCtD
Lamivudine—Diarrhoea—Paclitaxel—lung cancer	1.48e-05	0.000291	CcSEcCtD
Lamivudine—Malaise—Methotrexate—lung cancer	1.46e-05	0.000287	CcSEcCtD
Lamivudine—Dizziness—Etoposide—lung cancer	1.45e-05	0.000287	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—lung cancer	1.45e-05	0.000286	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—lung cancer	1.45e-05	0.000286	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—lung cancer	1.45e-05	0.000285	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—lung cancer	1.44e-05	0.000285	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—lung cancer	1.44e-05	0.000285	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—lung cancer	1.44e-05	0.000285	CcSEcCtD
Lamivudine—Chills—Doxorubicin—lung cancer	1.44e-05	0.000284	CcSEcCtD
Lamivudine—Dizziness—Paclitaxel—lung cancer	1.43e-05	0.000281	CcSEcCtD
Lamivudine—Nausea—Cisplatin—lung cancer	1.43e-05	0.000281	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—lung cancer	1.42e-05	0.00028	CcSEcCtD
Lamivudine—Cough—Methotrexate—lung cancer	1.41e-05	0.000278	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—lung cancer	1.4e-05	0.000276	CcSEcCtD
Lamivudine—Vomiting—Etoposide—lung cancer	1.4e-05	0.000276	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—lung cancer	1.4e-05	0.000276	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—lung cancer	1.4e-05	0.000276	CcSEcCtD
Lamivudine—Rash—Etoposide—lung cancer	1.39e-05	0.000273	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—lung cancer	1.39e-05	0.000273	CcSEcCtD
Lamivudine—Headache—Etoposide—lung cancer	1.38e-05	0.000272	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—lung cancer	1.38e-05	0.000272	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—lung cancer	1.37e-05	0.000271	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—lung cancer	1.37e-05	0.000271	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—lung cancer	1.37e-05	0.000271	CcSEcCtD
Lamivudine—Tension—Doxorubicin—lung cancer	1.37e-05	0.00027	CcSEcCtD
Lamivudine—Vomiting—Paclitaxel—lung cancer	1.37e-05	0.00027	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—lung cancer	1.37e-05	0.00027	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.36e-05	0.000269	CcSEcCtD
Lamivudine—Rash—Paclitaxel—lung cancer	1.36e-05	0.000268	CcSEcCtD
Lamivudine—Dermatitis—Paclitaxel—lung cancer	1.36e-05	0.000268	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—lung cancer	1.36e-05	0.000268	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—lung cancer	1.36e-05	0.000268	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—lung cancer	1.35e-05	0.000267	CcSEcCtD
Lamivudine—Headache—Paclitaxel—lung cancer	1.35e-05	0.000266	CcSEcCtD
Lamivudine—Hypersensitivity—Docetaxel—lung cancer	1.35e-05	0.000266	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—lung cancer	1.34e-05	0.000265	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—lung cancer	1.33e-05	0.000262	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—lung cancer	1.32e-05	0.00026	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—lung cancer	1.31e-05	0.000259	CcSEcCtD
Lamivudine—Infection—Methotrexate—lung cancer	1.31e-05	0.000258	CcSEcCtD
Lamivudine—Nausea—Etoposide—lung cancer	1.31e-05	0.000258	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—lung cancer	1.3e-05	0.000256	CcSEcCtD
Lamivudine—Pruritus—Docetaxel—lung cancer	1.29e-05	0.000255	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—lung cancer	1.29e-05	0.000255	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—lung cancer	1.29e-05	0.000255	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—lung cancer	1.29e-05	0.000254	CcSEcCtD
Lamivudine—Nausea—Paclitaxel—lung cancer	1.28e-05	0.000253	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—lung cancer	1.28e-05	0.000252	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—lung cancer	1.27e-05	0.000251	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—lung cancer	1.26e-05	0.000249	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—lung cancer	1.26e-05	0.000248	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—lung cancer	1.26e-05	0.000248	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—lung cancer	1.25e-05	0.000247	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—lung cancer	1.25e-05	0.000247	CcSEcCtD
Lamivudine—Diarrhoea—Docetaxel—lung cancer	1.25e-05	0.000247	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—lung cancer	1.23e-05	0.000243	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—lung cancer	1.23e-05	0.000242	CcSEcCtD
Lamivudine—Cough—Doxorubicin—lung cancer	1.22e-05	0.00024	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—lung cancer	1.21e-05	0.000239	CcSEcCtD
Lamivudine—Dizziness—Docetaxel—lung cancer	1.21e-05	0.000238	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methotrexate—lung cancer	1.2e-05	0.000237	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—lung cancer	1.19e-05	0.000235	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—lung cancer	1.19e-05	0.000235	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—lung cancer	1.19e-05	0.000235	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—lung cancer	1.19e-05	0.000235	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—lung cancer	1.19e-05	0.000234	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—lung cancer	1.18e-05	0.000233	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.18e-05	0.000233	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—lung cancer	1.18e-05	0.000232	CcSEcCtD
Lamivudine—Dyspnoea—Methotrexate—lung cancer	1.17e-05	0.000232	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—lung cancer	1.17e-05	0.000231	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—lung cancer	1.16e-05	0.000229	CcSEcCtD
Lamivudine—Vomiting—Docetaxel—lung cancer	1.16e-05	0.000229	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—lung cancer	1.16e-05	0.000229	CcSEcCtD
Lamivudine—Rash—Docetaxel—lung cancer	1.15e-05	0.000227	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—lung cancer	1.15e-05	0.000227	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—lung cancer	1.15e-05	0.000227	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—lung cancer	1.15e-05	0.000226	CcSEcCtD
Lamivudine—Headache—Docetaxel—lung cancer	1.15e-05	0.000226	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—lung cancer	1.14e-05	0.000225	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—lung cancer	1.14e-05	0.000225	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—lung cancer	1.14e-05	0.000224	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—lung cancer	1.14e-05	0.000224	CcSEcCtD
Lamivudine—Infection—Doxorubicin—lung cancer	1.13e-05	0.000223	CcSEcCtD
Lamivudine—Pain—Methotrexate—lung cancer	1.13e-05	0.000222	CcSEcCtD
Lamivudine—Shock—Doxorubicin—lung cancer	1.12e-05	0.000221	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—lung cancer	1.12e-05	0.000221	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—lung cancer	1.12e-05	0.00022	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—lung cancer	1.11e-05	0.000218	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—lung cancer	1.1e-05	0.000217	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—lung cancer	1.09e-05	0.000214	CcSEcCtD
Lamivudine—Nausea—Docetaxel—lung cancer	1.09e-05	0.000214	CcSEcCtD
Lamivudine—Feeling abnormal—Methotrexate—lung cancer	1.09e-05	0.000214	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—lung cancer	1.08e-05	0.000212	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—lung cancer	1.07e-05	0.00021	CcSEcCtD
Lamivudine—Urticaria—Methotrexate—lung cancer	1.05e-05	0.000206	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—lung cancer	1.04e-05	0.000205	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—lung cancer	1.04e-05	0.000205	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.04e-05	0.000205	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—lung cancer	1.03e-05	0.000203	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—lung cancer	1.02e-05	0.000202	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—lung cancer	1.02e-05	0.000201	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—lung cancer	1.01e-05	0.0002	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—lung cancer	1e-05	0.000198	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—lung cancer	9.92e-06	0.000196	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—lung cancer	9.85e-06	0.000194	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—lung cancer	9.83e-06	0.000194	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—lung cancer	9.75e-06	0.000192	CcSEcCtD
Lamivudine—Pain—Doxorubicin—lung cancer	9.75e-06	0.000192	CcSEcCtD
Lamivudine—Hypersensitivity—Methotrexate—lung cancer	9.71e-06	0.000191	CcSEcCtD
Lamivudine—Asthenia—Methotrexate—lung cancer	9.45e-06	0.000186	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—lung cancer	9.4e-06	0.000185	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—lung cancer	9.33e-06	0.000184	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—lung cancer	9.32e-06	0.000184	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—lung cancer	9.06e-06	0.000179	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—lung cancer	9.02e-06	0.000178	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—lung cancer	9.02e-06	0.000178	CcSEcCtD
Lamivudine—Diarrhoea—Methotrexate—lung cancer	9.01e-06	0.000178	CcSEcCtD
Lamivudine—Dizziness—Methotrexate—lung cancer	8.71e-06	0.000172	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—lung cancer	8.4e-06	0.000166	CcSEcCtD
Lamivudine—Vomiting—Methotrexate—lung cancer	8.38e-06	0.000165	CcSEcCtD
Lamivudine—Rash—Methotrexate—lung cancer	8.31e-06	0.000164	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—lung cancer	8.3e-06	0.000164	CcSEcCtD
Lamivudine—Headache—Methotrexate—lung cancer	8.25e-06	0.000163	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—lung cancer	8.18e-06	0.000161	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—lung cancer	8.07e-06	0.000159	CcSEcCtD
Lamivudine—Nausea—Methotrexate—lung cancer	7.82e-06	0.000154	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—lung cancer	7.8e-06	0.000154	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—lung cancer	7.54e-06	0.000149	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—lung cancer	7.25e-06	0.000143	CcSEcCtD
Lamivudine—Rash—Doxorubicin—lung cancer	7.19e-06	0.000142	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—lung cancer	7.19e-06	0.000142	CcSEcCtD
Lamivudine—Headache—Doxorubicin—lung cancer	7.15e-06	0.000141	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—lung cancer	6.78e-06	0.000134	CcSEcCtD
Lamivudine—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.06e-06	4.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TYMS—lung cancer	2.05e-06	4.75e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ENO1—lung cancer	2.04e-06	4.71e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.04e-06	4.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.03e-06	4.7e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—lung cancer	2.03e-06	4.69e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—lung cancer	2.03e-06	4.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2A7—lung cancer	2.02e-06	4.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.01e-06	4.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2e-06	4.64e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2A6—lung cancer	2e-06	4.63e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GCLC—lung cancer	2e-06	4.63e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	2e-06	4.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2e-06	4.63e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CB—lung cancer	1.99e-06	4.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RAF1—lung cancer	1.98e-06	4.58e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SDC4—lung cancer	1.98e-06	4.57e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—lung cancer	1.98e-06	4.57e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—lung cancer	1.97e-06	4.56e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	1.93e-06	4.45e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A1—lung cancer	1.92e-06	4.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES1—lung cancer	1.91e-06	4.42e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ERCC2—lung cancer	1.91e-06	4.41e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.91e-06	4.41e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—lung cancer	1.91e-06	4.41e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	1.91e-06	4.41e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ENO1—lung cancer	1.9e-06	4.39e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.9e-06	4.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—STK11—lung cancer	1.87e-06	4.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.86e-06	4.29e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2E1—lung cancer	1.85e-06	4.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2E1—lung cancer	1.83e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NQO1—lung cancer	1.83e-06	4.22e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NQO1—lung cancer	1.81e-06	4.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.81e-06	4.18e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RRM1—lung cancer	1.8e-06	4.17e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA3—lung cancer	1.8e-06	4.17e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOA1—lung cancer	1.8e-06	4.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERCC2—lung cancer	1.79e-06	4.13e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—lung cancer	1.78e-06	4.11e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	1.78e-06	4.11e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—lung cancer	1.77e-06	4.09e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—lung cancer	1.76e-06	4.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.76e-06	4.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB3—lung cancer	1.75e-06	4.04e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	1.74e-06	4.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—lung cancer	1.73e-06	4e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	1.72e-06	3.99e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—lung cancer	1.72e-06	3.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.72e-06	3.97e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.71e-06	3.95e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2E1—lung cancer	1.7e-06	3.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—B4GALT5—lung cancer	1.69e-06	3.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NQO1—lung cancer	1.68e-06	3.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAT—lung cancer	1.68e-06	3.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.67e-06	3.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—lung cancer	1.67e-06	3.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.66e-06	3.84e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOA1—lung cancer	1.65e-06	3.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA4—lung cancer	1.65e-06	3.81e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—STK11—lung cancer	1.65e-06	3.81e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—lung cancer	1.64e-06	3.8e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—lung cancer	1.64e-06	3.79e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—lung cancer	1.64e-06	3.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—lung cancer	1.64e-06	3.79e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—lung cancer	1.63e-06	3.78e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—STK11—lung cancer	1.63e-06	3.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.63e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR1—lung cancer	1.63e-06	3.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—lung cancer	1.61e-06	3.72e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	1.61e-06	3.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA2—lung cancer	1.61e-06	3.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—lung cancer	1.6e-06	3.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—lung cancer	1.59e-06	3.68e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.58e-06	3.66e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—lung cancer	1.58e-06	3.65e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—POMC—lung cancer	1.56e-06	3.61e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA1—lung cancer	1.55e-06	3.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOA1—lung cancer	1.54e-06	3.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.54e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCC3—lung cancer	1.53e-06	3.54e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—lung cancer	1.52e-06	3.52e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CREBBP—lung cancer	1.52e-06	3.52e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—STK11—lung cancer	1.52e-06	3.51e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—lung cancer	1.51e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—lung cancer	1.51e-06	3.49e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—lung cancer	1.51e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—lung cancer	1.51e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ERCC2—lung cancer	1.5e-06	3.46e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C1—lung cancer	1.48e-06	3.43e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAT—lung cancer	1.48e-06	3.43e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAT—lung cancer	1.47e-06	3.39e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—lung cancer	1.44e-06	3.34e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—lung cancer	1.44e-06	3.33e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—lung cancer	1.44e-06	3.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UGT1A1—lung cancer	1.44e-06	3.33e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—POMC—lung cancer	1.43e-06	3.32e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—lung cancer	1.43e-06	3.3e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—lung cancer	1.42e-06	3.29e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—lung cancer	1.42e-06	3.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.41e-06	3.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—lung cancer	1.41e-06	3.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KIT—lung cancer	1.41e-06	3.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—lung cancer	1.4e-06	3.25e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—lung cancer	1.4e-06	3.24e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—lung cancer	1.4e-06	3.24e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CREBBP—lung cancer	1.4e-06	3.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGF—lung cancer	1.39e-06	3.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNG11—lung cancer	1.39e-06	3.21e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—lung cancer	1.38e-06	3.2e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAT—lung cancer	1.37e-06	3.16e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.37e-06	3.16e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—lung cancer	1.33e-06	3.08e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—lung cancer	1.33e-06	3.08e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—lung cancer	1.33e-06	3.07e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—lung cancer	1.33e-06	3.07e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—lung cancer	1.32e-06	3.06e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDOA—lung cancer	1.32e-06	3.06e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ERCC2—lung cancer	1.32e-06	3.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.31e-06	3.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—lung cancer	1.31e-06	3.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6R—lung cancer	1.31e-06	3.03e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—lung cancer	1.31e-06	3.02e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CREBBP—lung cancer	1.31e-06	3.02e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—lung cancer	1.31e-06	3.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ERCC2—lung cancer	1.3e-06	3.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOA1—lung cancer	1.29e-06	2.99e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—lung cancer	1.29e-06	2.99e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA3—lung cancer	1.28e-06	2.97e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—lung cancer	1.26e-06	2.91e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG2—lung cancer	1.25e-06	2.89e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADCY1—lung cancer	1.25e-06	2.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAP2K1—lung cancer	1.25e-06	2.89e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—lung cancer	1.24e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—lung cancer	1.24e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.24e-06	2.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO2—lung cancer	1.22e-06	2.83e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HPGDS—lung cancer	1.22e-06	2.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—lung cancer	1.22e-06	2.83e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPP2R1B—lung cancer	1.22e-06	2.81e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ERCC2—lung cancer	1.21e-06	2.81e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—lung cancer	1.21e-06	2.8e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—lung cancer	1.19e-06	2.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—lung cancer	1.18e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCLC—lung cancer	1.17e-06	2.72e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2A6—lung cancer	1.17e-06	2.72e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—lung cancer	1.15e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.15e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—lung cancer	1.14e-06	2.65e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOA1—lung cancer	1.14e-06	2.63e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOA1—lung cancer	1.13e-06	2.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—POMC—lung cancer	1.12e-06	2.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO1—lung cancer	1.11e-06	2.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.11e-06	2.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—lung cancer	1.11e-06	2.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAF1—lung cancer	1.11e-06	2.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CREBBP—lung cancer	1.09e-06	2.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—lung cancer	1.09e-06	2.53e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—lung cancer	1.09e-06	2.51e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTOR—lung cancer	1.08e-06	2.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—lung cancer	1.08e-06	2.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—lung cancer	1.08e-06	2.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—lung cancer	1.07e-06	2.48e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOA1—lung cancer	1.05e-06	2.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.04e-06	2.41e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—lung cancer	1.04e-06	2.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—lung cancer	1.04e-06	2.4e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—lung cancer	1.04e-06	2.39e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—lung cancer	1.03e-06	2.38e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—lung cancer	1.02e-06	2.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2E1—lung cancer	9.98e-07	2.31e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—lung cancer	9.98e-07	2.31e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—lung cancer	9.91e-07	2.29e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—POMC—lung cancer	9.89e-07	2.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NQO1—lung cancer	9.87e-07	2.28e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—POMC—lung cancer	9.79e-07	2.26e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CREBBP—lung cancer	9.63e-07	2.23e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—lung cancer	9.59e-07	2.22e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CREBBP—lung cancer	9.53e-07	2.2e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—lung cancer	9.52e-07	2.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.41e-07	2.18e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—lung cancer	9.36e-07	2.16e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—lung cancer	9.34e-07	2.16e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—lung cancer	9.13e-07	2.11e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—POMC—lung cancer	9.12e-07	2.11e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—lung cancer	9.05e-07	2.09e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—lung cancer	9.04e-07	2.09e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—lung cancer	9.02e-07	2.09e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—lung cancer	8.97e-07	2.07e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—lung cancer	8.92e-07	2.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—lung cancer	8.9e-07	2.06e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STK11—lung cancer	8.9e-07	2.06e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CREBBP—lung cancer	8.89e-07	2.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—lung cancer	8.66e-07	2e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—lung cancer	8.43e-07	1.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—lung cancer	8.35e-07	1.93e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—lung cancer	8.33e-07	1.93e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—lung cancer	8.32e-07	1.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—lung cancer	8.23e-07	1.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAT—lung cancer	8.01e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—lung cancer	7.98e-07	1.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—lung cancer	7.96e-07	1.84e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—lung cancer	7.89e-07	1.82e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—lung cancer	7.88e-07	1.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—lung cancer	7.82e-07	1.81e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—lung cancer	7.81e-07	1.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—lung cancer	7.76e-07	1.79e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—lung cancer	7.66e-07	1.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—lung cancer	7.65e-07	1.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—lung cancer	7.59e-07	1.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—lung cancer	7.57e-07	1.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—lung cancer	7.46e-07	1.72e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—lung cancer	7.34e-07	1.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—lung cancer	7.28e-07	1.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—lung cancer	7.17e-07	1.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—lung cancer	7.17e-07	1.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ERCC2—lung cancer	7.11e-07	1.65e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—lung cancer	7.04e-07	1.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—lung cancer	6.88e-07	1.59e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—lung cancer	6.81e-07	1.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—lung cancer	6.59e-07	1.52e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—lung cancer	6.56e-07	1.52e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—lung cancer	6.49e-07	1.5e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—lung cancer	6.35e-07	1.47e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—lung cancer	6.26e-07	1.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA1—lung cancer	6.15e-07	1.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—lung cancer	6.09e-07	1.41e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—lung cancer	6.05e-07	1.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—lung cancer	5.83e-07	1.35e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—lung cancer	5.75e-07	1.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—lung cancer	5.62e-07	1.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—lung cancer	5.52e-07	1.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—lung cancer	5.38e-07	1.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—POMC—lung cancer	5.35e-07	1.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CREBBP—lung cancer	5.21e-07	1.2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—lung cancer	4.94e-07	1.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—lung cancer	4.88e-07	1.13e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—lung cancer	4.85e-07	1.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—lung cancer	4.8e-07	1.11e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—lung cancer	4.51e-07	1.04e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—lung cancer	4.48e-07	1.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—lung cancer	4.3e-07	9.96e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—lung cancer	4.27e-07	9.86e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—lung cancer	3.97e-07	9.17e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—lung cancer	3.92e-07	9.07e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—lung cancer	3.72e-07	8.6e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—lung cancer	3.66e-07	8.46e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—lung cancer	3.55e-07	8.2e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—lung cancer	2.62e-07	6.07e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—lung cancer	2.14e-07	4.96e-06	CbGpPWpGaD
